Seeking Alpha USD valuations. (hint multiply by 1.31)Valuation summary (all share prices in US dollars) Fair valuation today: $300 million. Shareprice: $1.04. Fair valuation following positive advisory committee recommendation: $600 million. Shareprice: $2.08. Fair valuation following 2nd Phase 3 trial recommendation: $150 million. Shareprice: $.52. For valuation following 2nd phase 3 trial recommendation with concurrent FDA approved drug sales: valuation $400 million. Shareprice: $1.38. Fair valuation following FDA approval: $1 billion. Shareprice: $3.47. Fair valuation long-term following FDA approval: $3 billion to $4.5 billion. Shareprice: $10.41 to $15.62. NICE. beech